Randomized Trialhigh evidence
An integrated lifestyle intervention for mitigation of adverse effects associated with androgen deprivation therapy for prostate cancer (STAMINA): a multicentre, randomised trial.
The Lancet. Oncology·September 4, 2026·PMID 42697217
Why it mattersAndrogen deprivation therapy causes significant quality-of-life and fatigue burdens, yet supervised exercise is rarely integrated into prostate cancer care. This trial provides robust evidence that a structured lifestyle program can be embedded in routine NHS practice and yields meaningful patient-centered benefits.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled